View:
Download DOC
Download PDF
SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 		 
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
LEBLANC ROBERT M
(Last) (First) (Middle)
55 NOD ROAD
(Street)
AVON CT 06001
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MAGELLAN HEALTH SERVICES INC [ MGLN ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
05/15/2007
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Common Stock, $0.01 par value(1) 05/15/2007 A 750(2) A $0(5) 1,500 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $44.49 05/15/2007(3) A 6,264 05/15/2008(4) 05/15/2017 Common Stock 6,264 $0(5) 6,264 D
Explanation of Responses:
1. The restricted shares were granted pursuant to the 2006 Director Equity Compensation Plan.
2. Shares shall vest fully in one year from the date of grant.
3. The option grant was made pursuant 2006 Director Equity Compensation Plan. The exercise price of the options was the fair market value on the date of grant determined by using the closing price of the Issuer's Ordinary Common Stock on NASDAQ on May 15, 2007.
4. Options vest and become exercisable in one year from the date of grant.
5. Not applicable.
Remarks:
See Exhibit 24.
/s/ Daniel Gregoire as Attorney In Fact for Robert LeBlanc 05/17/2007
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
rrd140387_158175.html 
LIMITED POWER OF ATTORNEY FOR
SECTION 16 REPORTING OBLIGATIONS


	Know all by these presents, that the undersigned hereby makes, constitutes
and
appoints each of Daniel Gregoire and Mark Demilio, each acting individually, as
the
undersigned's true and lawful attorney-in-fact, with full power and authority as
hereinafter described on behalf of and in the name, place and stead of the
undersigned to:

(1)	prepare, execute, acknowledge, deliver and file Forms, 3, 4, and 5
(including any
amendments thereto) with respect to the securities of Magellan Health Services,
Inc., a
Delaware Corporation (the "Company"), with the United States Securities and
Exchange
Commission, any national securities exchanges and the Company, as considered
necessary or advisable under Section 16(a) of the Securities Exchange Act of
1934 and
the rules and regulations promulgated thereunder, as amended from time to time
(the
"Exchange Act");

(2)	seek or obtain, as the undersigned's representative and on the
undersigned's
behalf, information on transactions in the Company's securities from any third
party,
including brokers, employee benefit plan administrators and trustees, and the
undersigned
hereby authorizes any such person to release any such information to the
undersigned and
approves and ratifies any such release of information; and

(3)	perform any and all other acts which in the discretion of such attorney-
in-fact are
necessary or desirable for an on behalf of the undersigned in connection with
the
foregoing.

	The undersigned acknowledges that:

(1)	this Power of Attorney authorizes, but does not require, each such
attorney-in-fact
to act in their discretion on information provided to such attorney-in-fact
without
independent verification of such information;

(2)	any documents prepared and/or executed by either such attorney-in-fact on
behalf
of the undersigned pursuant to this Power of Attorney will be in such form and
will
contain such information and disclosure as such attorney-in-fact, in his or her
discretion,
deems necessary or desirable;

(3)	neither the Company nor either of such attorneys-in-fact assumes (i) any
liability
for the undersigned's responsibility to comply with the requirements of the
Exchange
Act, (ii) any liability of the undersigned for any failure to comply with such
requirements,
or (iii) any obligation or liability of the undersigned for profit disgorgement
under
Section 16(b) of the Exchange Act; and

(4)	this Power of Attorney does not relieve the undersigned from
responsibility for
compliance with the undersigned's obligations under the Exchange Act, including
without limitation the reporting requirements under Section 16 of the Exchange
Act.

      The undersigned hereby gives and grants each of the foregoing attorneys-
in-fact
full power and authority to do and perform all and every act and thing
whatsoever
requisite, necessary or appropriate to be done in and about the foregoing
matters as fully
to all intents and purposes as the undersigned might or could do if present,
hereby
ratifying all that each such attorney-in-fact of, for and on behalf of the
undersigned, shall
lawfully do or cause to be done by virtue of this Limited Power of Attorney.

      The Power of Attorney shall remain in full force and effect until revoked
by the
undersigned in a signed writing delivered to each such attorney-in-fact.

      IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 15th day of May, 2007.


						/s/ Barry Smith
						Signature

						Barry Smith
						___________________________________
						Print Name